Home > Insider Trading > Filing (0001209191-13-053549)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1197036	I Bruce Sachs	C/O Vertex Pharmaceuticals Incorporated 130 Waverly St. Cambridge MA 02139		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2013-11-20	700	$63.10	62,410	No	4	S	Direct
Common Stock	Disposition	2013-11-20	800	$64.21	61,610	No	4	S	Direct
Common Stock	Disposition	2013-11-20	4,900	$65.35	56,710	No	4	S	Direct
Common Stock	Disposition	2013-11-20	1,700	$66.25	55,010	No	4	S	Direct
Common Stock	Disposition	2013-11-20	200	$67.15	54,810	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $63.10 (range $62.80 to $63.33).
Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $64.21 (range $63.82 to $64.62).
Open market sales reported on this line occurred at a weighted average price of $65.35 (range $64.92 to $65.86).
Open market sales reported on this line occurred at a weighted average price of $66.25 (range $66.00 to $66.80).
Open market sales reported on this line occurred at a weighted average price of $67.15 (range $67.14 to $67.16).